Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study
Angelo Sangiovanni(Ospedale Maggiore), Giorgio Minoli(Ospedale Valduce), Giancarlo Spinzi(Ospedale Valduce), Rino Morales(Ospedale Santa Corona), E Tavani, Maurizio Fossati(Faculdade São Leopoldo Mandic), Maria Grazia Rumi(University of Milan), Enrico Colombo(Université Paris Cité), A Casiraghi(Azienda Ospedaliera Ospedale Civile di Legnano), Alberto Prada, Roberto Ceriani(Paoli Hospital)
Cited by 91
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607